ACTIVE

TM Pharma

Financial year 2025 · Closed on 31/12/2025

Net result-45,4 k €-478,6 %over 1 year

Gross margin49,1 k €-41,3 %over 1 year

Equity916,3 k €-4,7 %over 1 year

Identity

Source · BCE/KBO

TM Pharma is a Private limited company incorporated in 2006. Its main activity is: Management consultancy activities. Its registered office is in Edegem.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0881.130.182
Incorporation: 05/05/2006
Legal form: Private limited company
Registered office: Leopold III-lei 13
2650 Edegem · FlandreSee on map
Contributed capital: 18 600,00 €
Latest accounts: 31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 74142Specialised design activities 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	49,1 k €	-41.3%	83,8 k €	-12.5%	95,7 k €	-28.7%	134,2 k €	+37.5%	97,6 k €
EBITDA	36,2 k €	-49.4%	71,6 k €	-16.7%	86 k €	-32.6%	127,6 k €	+43.1%	89,1 k €
Operating result	-49,8 k €	-1758%	3 k €	-83.9%	18,7 k €	-74.3%	72,5 k €	+167%	27,1 k €
Net result	-45,4 k €	-479%	12 k €	-56.9%	27,8 k €	-71.0%	95,8 k €	+121%	43,4 k €
Balance sheet
Equity	916,3 k €	-4.7%	961,7 k €	+1.3%	949,7 k €	+3.0%	922 k €	-18.1%	1,1 M €
Total assets	1,7 M €	+14.9%	1,5 M €	+8.5%	1,3 M €	-17.2%	1,6 M €	-6.2%	1,7 M €
Cash	117,6 k €	+639%	15,9 k €	+71.0%	9,3 k €	-85.6%	64,7 k €	+624%	8,9 k €
Debts	766,3 k €	+52.6%	502,2 k €	+25.7%	399,5 k €	-43.6%	708,3 k €	+16.0%	610,7 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Mieke Raemdonck	Directorsince 24/04/2006Manager2018 accountsended
Tom Claes	Directorsince 24/04/2006Manager2018 accountsended

Other companies at this address

Leopold III-lei 13 2650 Edegem

Company	CBE no.
CAM Immo● Active	0518.885.860
PROJECT AARTSELAAR● Active	0535.615.885
STAB Immo● Active	0677.509.663

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	30/07/2025	16/08/2024	18/07/2023	15/07/2022	30/07/2021
General meeting	22/06/2026	30/06/2025	17/06/2024	19/06/2023	20/06/2022	21/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	22/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	30/06/2025	30/07/2025	Dutch	PDF
Abridged model	31/12/2023	17/06/2024	16/08/2024	Dutch	PDF
Abridged model	31/12/2022	19/06/2023	18/07/2023	Dutch	PDF
Abridged model	31/12/2021	20/06/2022	15/07/2022	Dutch	PDF
Abridged model	31/12/2020	21/06/2021	30/07/2021	Dutch	PDF
Abridged model	31/12/2019	22/06/2020	26/06/2020	Dutch	PDF
Abridged model	31/12/2018	17/06/2019	28/06/2019	Dutch	PDF
Abridged model	31/12/2017	18/06/2018	19/06/2018	Dutch	PDF
Abridged model	31/12/2016	19/06/2017	18/07/2017	Dutch	PDF
Abridged model	31/12/2015	20/06/2016	26/07/2016	Dutch	PDF
Abridged model	31/12/2014	22/06/2015	31/07/2015	Dutch	PDF
Abridged model	31/12/2013	14/04/2014	05/08/2014	Dutch	PDF
Abridged model	31/12/2012	17/03/2013	30/07/2013	Dutch	PDF
Abridged model	31/12/2011	18/06/2012	26/07/2012	Dutch	PDF
Abridged model	31/12/2010	02/05/2011	25/07/2011	Dutch	PDF
Abridged model	31/12/2009	21/06/2010	13/08/2010	Dutch	PDF
Abridged model	31/12/2008	22/06/2009	29/07/2009	Dutch	PDF
Abridged model	31/12/2007	23/06/2008	15/07/2008	Dutch	PDF
Abridged model	31/12/2006	18/06/2007	04/07/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Mieke Raemdonck	Directorsince 24/04/2006Manager2018 accountsended
Tom Claes	Directorsince 24/04/2006Manager2018 accountsended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates17/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares22/03/2018
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other15/01/2014
REGIME ARTIKEL 537 WIB — UITKERING TUSSENTIJDS DIVIDEND — !
PDF
Other27/09/2012
Uittreksel Bijzondere Algemene Vergadering van 8 september 2012 inzake
PDF
Other16/05/2006
Oprichting en benoemingen
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

Mieke Raemdonck

Tom Claes

200620072008200920102011201220132014201520162017201820192020202120222023202420252026

T&M Pharma

Leopold III-lei 13, 2650 Edegem

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Leopold III-lei 13, 2650 EdegemCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00228054

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
TM PharmaCurrent		CBE
T&M Pharma	accounts 2021 → 2025	Accounts 2025 · 2026-00228054

Events

2025
Annual accounts 2025-45,4 k €↓
2024
Annual accounts 202412 k €↓
2023
Annual accounts 202327,8 k €↓
2022
Annual accounts 202295,8 k €↑
2021
Annual accounts 202143,4 k €↑
2020
Annual accounts 202029,9 k €↑
2019
Annual accounts 2019-11,5 k €↑
2018
Annual accounts 2018-37 k €↑
2017
Annual accounts 2017-165,3 k €↓
2016
Annual accounts 20161,1 M €↑
2015
Annual accounts 201581,9 k €↓
2014
Annual accounts 2014117,7 k €↑
2013
Annual accounts 201395,5 k €↑
2012
Annual accounts 201295 k €↓
2011
Annual accounts 2011117,1 k €↑
2010
Annual accounts 201042,8 k €↓
2009
Annual accounts 200980,3 k €↑
2008
Annual accounts 200852 k €↓
2007
Annual accounts 200758,9 k €↑
2006
Annual accounts 20067 k €
05/05/2006
IncorporationPrivate limited company

TM Pharma

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events